IL229204A - Hydroxystilbins that carry paranilations, medicinal preparations and their uses - Google Patents
Hydroxystilbins that carry paranilations, medicinal preparations and their usesInfo
- Publication number
- IL229204A IL229204A IL229204A IL22920413A IL229204A IL 229204 A IL229204 A IL 229204A IL 229204 A IL229204 A IL 229204A IL 22920413 A IL22920413 A IL 22920413A IL 229204 A IL229204 A IL 229204A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- hydroxystilbenes
- prenylated
- prenylated hydroxystilbenes
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/235—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring
- C07C43/253—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
- A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
- C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
- C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
- C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
- C07C39/215—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring containing, e.g. diethylstilbestrol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/293—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011901663A AU2011901663A0 (en) | 2011-05-04 | Prenylated Hydroxystilbenes | |
| PCT/AU2012/000482 WO2012149608A1 (en) | 2011-05-04 | 2012-05-04 | Prenylated hydroxystilbenes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL229204A0 IL229204A0 (en) | 2014-01-30 |
| IL229204A true IL229204A (en) | 2016-11-30 |
Family
ID=47107689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL229204A IL229204A (en) | 2011-05-04 | 2013-10-31 | Hydroxystilbins that carry paranilations, medicinal preparations and their uses |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10196335B2 (enExample) |
| EP (1) | EP2709975B1 (enExample) |
| JP (2) | JP6297485B2 (enExample) |
| KR (1) | KR101907716B1 (enExample) |
| CN (2) | CN107266297B (enExample) |
| AU (1) | AU2012250497C1 (enExample) |
| CA (1) | CA2833780C (enExample) |
| DK (1) | DK2709975T3 (enExample) |
| ES (1) | ES2909403T3 (enExample) |
| IL (1) | IL229204A (enExample) |
| PT (1) | PT2709975T (enExample) |
| SG (2) | SG194582A1 (enExample) |
| WO (1) | WO2012149608A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG194582A1 (en) * | 2011-05-04 | 2013-12-30 | Univ Sydney | Prenylated hydroxystilbenes |
| US9642829B2 (en) * | 2012-12-04 | 2017-05-09 | The University Of Hong Kong | Antifungal compound and uses thereof |
| FR3030511B1 (fr) * | 2014-12-22 | 2018-04-06 | L'oreal | Composes 1-phenyl (3,4,5-trisubstitues), 2-phenyl (3,5-disubstitues) ethylene et leur utilisation. |
| FR3030508B1 (fr) * | 2014-12-22 | 2017-06-23 | Oreal | Composes 1-phenyl (3,4-disubstitues) 2-phenyl (3,5-disubstitues) ethylene et leur utilisation |
| FR3030510B1 (fr) | 2014-12-22 | 2017-02-03 | Oreal | Composes 1-phenyl (3,4-disubstitues), 2-phenyl (3,4-disubstitues) ethane et leur utilisation |
| CN109952095B (zh) * | 2016-09-07 | 2022-05-03 | 凯楠公爵Ip有限责任公司 | 细齿烷二萜类的药物用途 |
| CN110183414B (zh) * | 2019-07-25 | 2019-10-25 | 江西中医药大学 | 二色波罗蜜中的一种异戊烯基二苯乙烯及其在制备治疗炎症性疾病药物中的用途 |
| CN110183311B (zh) * | 2019-07-25 | 2019-10-29 | 江西中医药大学 | 一种异戊烯基芪及其在制备治疗炎症性疾病药物中的用途 |
| IL294179B2 (en) * | 2019-12-23 | 2026-04-01 | Kynan Duke Ip Llc | Modified hydroxystilbene compounds, their derivatives, method for their preparation and use. |
| CN111579682A (zh) * | 2020-05-29 | 2020-08-25 | 山东师范大学 | 一种针对不同蜂胶产品差异性代谢物的分析方法及其应用 |
| CN114573430B (zh) * | 2022-03-10 | 2022-09-06 | 中国科学院华南植物园 | 一种甘草抗炎物质及其制备方法 |
| JP7614652B2 (ja) * | 2022-08-12 | 2025-01-16 | 株式会社山田養蜂場本社 | ステロイド－５α－リダクターゼ阻害剤 |
| JP7849021B2 (ja) * | 2022-09-14 | 2026-04-21 | 株式会社山田養蜂場本社 | Ｓｉｒｔ１活性化剤 |
| WO2024249297A2 (en) * | 2023-05-26 | 2024-12-05 | Cambium Biomaterials, Inc. | Polymeric compositions with prenylated stilbenes |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0717859A (ja) | 1993-06-30 | 1995-01-20 | Tsumura & Co | アラキドン酸代謝異常疾患治療剤 |
| KR20030011980A (ko) | 2001-07-23 | 2003-02-12 | 주식회사 태평양 | 스틸벤 유도체를 유효성분으로 포함하는 과색소 침착치료용 의약 조성물 |
| WO2003009807A2 (en) | 2001-07-23 | 2003-02-06 | Galileo Laboratories, Inc. | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| WO2003010121A1 (en) | 2001-07-23 | 2003-02-06 | Pacific Corporation | Stilbene derivatives, a method for preparation thereof, and its use |
| US6737439B2 (en) | 2001-08-07 | 2004-05-18 | The Board Of Trustees Of The University Of Illinois | Aromatase inhibitors from Broussonetia papyrifera |
| CN100342862C (zh) * | 2003-06-27 | 2007-10-17 | 中国医学科学院药物研究所 | 白藜芦醇低聚茋类化合物及其制法和其药物组合物与用途 |
| GB2411353A (en) | 2004-02-25 | 2005-08-31 | Univ Hertfordshire | Resveratrol Analogues |
| CN1331856C (zh) * | 2005-08-05 | 2007-08-15 | 大连理工大学 | 多羟基茋类化合物的制备和抑制sars病毒药物的用途 |
| US7781580B2 (en) * | 2007-04-23 | 2010-08-24 | Virginia Commonwealth University | Stilbene derivatives as new cancer therapeutic agents |
| CN100503539C (zh) * | 2007-06-14 | 2009-06-24 | 复旦大学 | 一种具有抗肿瘤活性的二苯乙烯类化合物及其制备方法 |
| WO2009012910A1 (en) | 2007-07-20 | 2009-01-29 | Universita'degli Studi Di Milano | Biologically-active stilbene derivatives and compositions thereof |
| JP2012503595A (ja) * | 2008-07-28 | 2012-02-09 | シダンスク ユニバーシティ | 代謝病の治療用の化合物 |
| US20130310611A1 (en) * | 2010-10-28 | 2013-11-21 | Uha Mikakuto Co., Ltd. | Process for production of phenolic polymerizable compound having physiological activity |
| US9340477B2 (en) * | 2010-11-26 | 2016-05-17 | Uha Mikakuto Co., Ltd. | Process for production of hydroxystilbene derivative having physiological activity |
| SG194582A1 (en) * | 2011-05-04 | 2013-12-30 | Univ Sydney | Prenylated hydroxystilbenes |
| JP7017859B2 (ja) | 2017-03-21 | 2022-02-09 | 日鉄鋼板株式会社 | 建築パネル |
-
2012
- 2012-05-04 SG SG2013078589A patent/SG194582A1/en unknown
- 2012-05-04 SG SG10201603776RA patent/SG10201603776RA/en unknown
- 2012-05-04 JP JP2014508649A patent/JP6297485B2/ja active Active
- 2012-05-04 CN CN201710431414.3A patent/CN107266297B/zh active Active
- 2012-05-04 CN CN201280033556.XA patent/CN103649031A/zh active Pending
- 2012-05-04 PT PT127798890T patent/PT2709975T/pt unknown
- 2012-05-04 ES ES12779889T patent/ES2909403T3/es active Active
- 2012-05-04 WO PCT/AU2012/000482 patent/WO2012149608A1/en not_active Ceased
- 2012-05-04 EP EP12779889.0A patent/EP2709975B1/en active Active
- 2012-05-04 AU AU2012250497A patent/AU2012250497C1/en active Active
- 2012-05-04 CA CA2833780A patent/CA2833780C/en active Active
- 2012-05-04 US US14/115,574 patent/US10196335B2/en active Active
- 2012-05-04 KR KR1020137032115A patent/KR101907716B1/ko active Active
- 2012-05-04 DK DK12779889.0T patent/DK2709975T3/da active
-
2013
- 2013-10-31 IL IL229204A patent/IL229204A/en active IP Right Grant
-
2018
- 2018-02-21 JP JP2018028572A patent/JP6461398B2/ja active Active
- 2018-12-17 US US16/221,666 patent/US10696615B2/en active Active
-
2020
- 2020-06-30 US US16/916,461 patent/US11352310B2/en active Active
-
2022
- 2022-05-26 US US17/825,827 patent/US11634375B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
| IL245326A0 (en) | pharmaceutical preparation | |
| PT2619182T (pt) | Composição farmacêutica | |
| IL225457A0 (en) | Pharmaceutical composition | |
| ZA201501930B (en) | Pharmaceutical composition | |
| ZA201209739B (en) | Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof | |
| IL227626A0 (en) | A compound of 17-il and γ-ifn inhibitors, preparations containing them and their uses | |
| SI2782559T1 (sl) | Farmacevtski sestavek, ki vsebuje mio-inozitol | |
| IL229204A0 (en) | Hydroxystilbenes are converted by prenyl | |
| EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
| GB201010453D0 (en) | Pharmaceutical composition | |
| EP2924042A4 (en) | BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| IL228705A (en) | Derivatives of Reliable Phenoxy-Ethyl, Pharmaceutical Preparations Containing and Using Them | |
| ZA201302012B (en) | Low dose pharmaceutical composition | |
| EP2766183A4 (en) | IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF | |
| IL226554A (en) | Medicinal preparations containing alisporiovir | |
| IL221501A (en) | Medicinal product containing miramistine | |
| PT2672985T (pt) | Composições farmacêuticas compreendendo anakinra sem citrato | |
| ZA201502987B (en) | Pharmaceutical composition | |
| PL3097920T3 (pl) | Kompozycja medyczna zawierająca ekstrakt stauntonia hexaphylla | |
| GB201001911D0 (en) | Pharmaceutical composition | |
| HK1191929A (en) | Prenylated hydroxystilbenes | |
| AU2011901663A0 (en) | Prenylated Hydroxystilbenes | |
| AP2011006026A0 (en) | Medicinal and herbal composition. | |
| ZA201309537B (en) | Pharmaceutical composition comprising fexofedine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |